| 2025-12-03 |
详情>>
内部人交易：
Hopkinson Craig C.共交易2笔
|
| 2025-10-28 |
详情>>
股本变动：
变动后总股本16511.75万股
|
| 2025-10-28 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.17美元,归母净利润1.92亿美元,同比去年增长-12.81%
|
| 2025-10-28 |
财报披露：
美东时间 2025-10-28 盘前发布财报
|
| 2025-07-29 |
详情>>
业绩披露：
2025年中报每股收益0.67美元,归母净利润1.10亿美元,同比去年增长-14.53%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益0.14美元,归母净利润2246.40万美元,同比去年增长-39%
|
| 2025-04-07 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, each of the following director nominees to serve on the Company’s Board of Directors (the “Board”) for a one-year term until the Company’s 2026 annual general meeting of shareholders:
2.To approve, in a non-binding, advisory vote, the compensation of the Company’s named executive officers.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To renew Board authority to allot and issue shares under Irish law.
6.To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.
7.To transact such other business as may properly come before the Annual Meeting.
|
| 2025-02-12 |
详情>>
业绩披露：
2022年年报每股收益-0.97美元,归母净利润-1.58亿美元,同比去年增长-228.57%
|
| 2025-02-12 |
详情>>
业绩披露：
2024年年报每股收益2.22美元,归母净利润3.67亿美元,同比去年增长3.18%
|
| 2024-10-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.32美元,归母净利润2.21亿美元,同比去年增长-9.22%
|
| 2024-07-24 |
详情>>
业绩披露：
2024年中报每股收益0.76美元,归母净利润1.28亿美元,同比去年增长-34.34%
|
| 2024-07-24 |
详情>>
业绩披露：
2023年中报每股收益1.18美元,归母净利润1.95亿美元,同比去年增长395.61%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益0.22美元,归母净利润3682.80万美元,同比去年增长188.01%
|
| 2024-04-15 |
股东大会：
将于2024-05-31召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Non-Binding, Advisory Vote on Executive Compensation
3.Non-Binding, Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation
4.Non-Binding Ratification of Appointment of Independent Auditor and Accounting Firm and Binding Authorization of Audit and Risk Committee to Set Independent Auditor and Accounting Firm’s Remuneration
5.Approval of Alkermes plc 2018 Stock Option and Incentive Plan, as amended
6.Renewal of Board Authority to Allot and Issue Shares under Irish Law
7.Renewal of Board Authority to Disapply the Statutory Pre-emption Rights under Irish Law
|
| 2024-02-21 |
详情>>
业绩披露：
2023年年报每股收益2.14美元,归母净利润3.56亿美元,同比去年增长324.78%
|
| 2023-10-25 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.46美元,归母净利润2.43亿美元,同比去年增长286.89%
|
| 2023-05-25 |
股东大会：
将于2023-06-29召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on the Company’s Board of Directors (the “Board”) from those individuals validly nominated by the Board or by any shareholder of the Company for election at the Annual Meeting in accordance with the Company’s articles of association (the “Articles of Association”).
2.To approve, in a non-binding, advisory vote, the compensation of the Company’s named executive officers.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To renew Board authority to allot and issue shares under Irish law.
6.To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.
7.To transact such other business as may properly come before the meeting and any adjournments or postponements thereof.
|
| 2022-06-06 |
股东大会：
将于2022-07-07召开股东大会
会议内容 ▼▲
- 1.To elect four Class II directors to serve on the Company’s Board of Directors (the “Board”) from those individuals validly nominated by the Board or by any shareholder of the Company for election at the Annual Meeting in accordance with the Company’s articles of association (the “Articles of Association”).
2.To approve, in a non-binding, advisory vote, the compensation of the Company’s named executive officers.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To renew Board authority to allot and issue shares under Irish law.
6.To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.
7.To transact such other business as may properly come before the meeting and any adjournments or postponements thereof.
|
| 2022-04-18 |
股东大会：
将于2022-05-13召开股东大会
会议内容 ▼▲
- 1.To approve certain amendments to the Company’s Articles of Association to provide for plurality voting for contested elections.
2.To transact such other business as may properly come before the meeting and any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-01 |
复牌提示：
2021-06-01 06:55:00 停牌，复牌日期 2021-06-01 07:30:00
|
| 2021-05-10 |
股东大会：
将于2021-06-14召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class I directors the following individuals as nominated by the Company’s Board of Directors (the “Board”):
a.David A. Daglio, Jr.
b.Nancy L. Snyderman, M.D.
c.Frank Anders Wilson
d.Nancy J. Wysenski
2.To approve, in a non-binding, advisory vote, the compensation of the Company’s named executive officers.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To approve certain amendments to the Company’s Articles of Association that would serve to declassify the Board.
6.To transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|
| 2020-04-03 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class III directors to serve for a three-year term expiring at the Company’s Annual General Meeting of Shareholders in 2023 or until their respective successors are elected and shall qualify, the following individuals as nominated by the Company’s Board of Directors (the “Board”): a.Shane M. Cooke, b.Richard B. Gaynor, M.D., c.Paul J. Mitchell, d.Richard F. Pops
2.To approve, in a non-binding, advisory vote, the compensation of the Company’s named executive officers.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|
| 2019-04-05 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class II directors to serve for a three-year term expiring at the Company’s Annual General Meeting of Shareholders in 2022 or until their respective successors are elected and shall qualify, the following individuals as nominated by the Company’s Board of Directors (the “Board”):
a. David W. Anstice AO
b. Robert A. Breyer
c. Wendy L. Dixon, Ph.D.
2.To hold a non-binding, advisory vote to approve executive compensation.
3.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.
5.To transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|
| 2018-04-10 |
股东大会：
将于2018-05-23召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class I directors to serve for a three-year term expiring at the Company’s Annual General Meeting of Shareholders in 2021 or until their respective successors are elected and shall qualify, the following individuals as nominated by the Company’s Board of Directors (the “Board”):
a.Floyd E. Bloom, M.D.
b.Nancy L. Snyderman, M.D.
c.Nancy J. Wysenski
2.To hold a non-binding, advisory vote to approve executive compensation.
n-binding, advisory vote on the frequency of future advisory votes on executive compensation.
4.To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
5.To approve the Alkermes plc 2018 Stock Option and Incentive Plan.
6.To transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|
| 2017-04-13 |
股东大会：
将于2017-05-24召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class III directors to serve for a three-year term expiring at the Company’s Annual General Meeting of Shareholders in 2020 and until their respective successors are elected and shall qualify, the following individuals as nominated by the Company’s Board of Directors (the “Board”):
a.Paul J. Mitchell
b.Richard F. Pops
2.To hold a non-binding, advisory vote on the compensation of the Company’s named executive officers.
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize the Audit and Risk Committee of the Board to set the independent auditor and accounting firm’s remuneration.
4.To approve the Alkermes plc 2011 Stock Option and Incentive Plan, as amended.
5.To grant the Board the authority to allot and issue shares under Irish law.
|
| 2016-04-13 |
股东大会：
将于2016-05-25召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to elect as Class II directors to serve for a three-year term expiring at the Company's Annual General Meeting of Shareholders in 2019 and until their respective successors are elected and shall qualify, the following individuals as nominated by the Company's Board of Directors (the "Board"):
a.David W. Anstice
b.Robert A. Breyer
c.Wendy L. Dixon, Ph.D.
2.To hold a non-binding, advisory vote on the compensation of the Company's named executive officers.
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize the Audit and Risk Committee of the Board of Directors to set the independent auditor and accounting firm's remuneration.
4.To approve the Alkermes plc 2011 Stock Option and Incentive Plan, as amended.
5.To grant the Board the authority to issue shares under Irish law.
6a.To approve certain amendments to the Company's Articles of Association that address the adoption of the Irish Companies Act 2014.
6b.To approve certain amendments to the Company's Memorandum of Association that address the adoption of the Irish Companies Act 2014.
7.To grant the Board the authority to opt-out of statutory pre-emption rights under Irish law.
8. To transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
|